MEXICO CITY — Mexico says it will get its first shipment of the Chinese Coronavac vaccine Saturday and by Monday will receive its first lot of the Russian Sputnik V shot. Both shipments are expected to consist of about 200,000 doses.
Health officials say the first shipments of the Chinese and Russian vaccines will be used in low-income neighborhoods of Mexico City or its suburbs.
Mexico is currently using the Pfizer and AstraZeneca vaccines and has applied almost 1.6 million doses of those.
The country will now be faced with the logistical challenge of handling four different vaccines, all of which require two doses. In addition, the Sputnik first shot is different from the second and is not interchangeable.
GENEVA (AP) — The World Health Organization said Friday that COVID-19 no longer qualifies as a global emergency, marking a symbolic end to the devastating coronavirus pandemic that triggered once-unthinkable lockdowns, upended economies and killed millions of people worldwide.
FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.
Explore articles from the past and connect to your heritage!
Discover the benefits of a subscription including access to exclusive content, events, and more!
Have an idea for a story, or know of an event we should cover? We want to hear about it!
The National Herald is the paper of record of the Greek Diaspora community. Through independent journalism, we bring news to generations of Greek-Americans, with stories on the individual, community and international level. Visit and support our 106 year-old sister publication Εθνικός Κήρυξ.
To purchase a gift subscription, please log out of your account, and purchase the subscription with a new email ID.
Sign up to receive our daily email news briefing.
Sign up for a subscription to The National Herald,
starting as low as $1/week.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
We use cookies on our site to personalize your experience, bring you the most relevant content, show you the most useful ads, and to help report any issues with our site. You can update your preferences at any time by visiting preferences. By selecting Accept, you consent to our use of cookies. To learn more about how your data is used, visit our cookie policy.
$1.07 USD
